Enveric Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-2.7M | $-2.7M | — | $1.5M |
| FY2017 | $-2.7M | $-2.7M | — | $7.1M |
| FY2018 | $-2.6M | $-2.6M | — | — |
| FY2019 | $-647.9K | $-647.9K | — | $624.1K |
| FY2020 | $-3.9M | $-3.9M | — | $2.0M |
| FY2021 | $-11.5M | $-11.6M | $189.7K | $12.6M |
| FY2022 | $-17.1M | $-17.7M | $584.2K | $2.6M |
| FY2023 | $-14.1M | $-14.1M | $5.2K | $2.2M |
| FY2024 | $-7.7M | $-7.7M | — | $1.6M |
| FY2025 | $-8.1M | $-8.1M | — | $827.3K |